logoCUN_Negro.png
Logo%20REFINE_v1_trazado_edited.png
Spanish
Español
Spanish
Español
English
Inicio
Estado Actual
Sobre Nosotros
Publicaciones
Contacto
Área Privada
PUBLICACIONES

Sullivan FM et al.  Early Diagnosis of Lung Cancer Scotland (ECLS) Team. Earlier diagnosis of lung cancer in a randomised trial of an autoantibody blood test followed by imaging. Eur Respir J. 2020,30:2000670.

Jul

2020

Tanner NT et al. Effect of a Rule-in Biomarker Test on Pulmonary Nodule Management: A Survey of Pulmonologists and Thoracic Surgeons. Clin Lung Cancer. 2020;21:e89-e98.

Mar

2020

Jett J. et al. Potential utility of a positive EarlyCDT®-Lung blood biomarker test in indeterminate pulmonary nodules. Journal of Thoracic Oncology, 2018; 13:10S.

Oct

2018

Edelsberg J. et al. Cost-effectiveness of an autoantibody test (EarlyCDT-Lung) as an aid to early diagnosis of lung cancer in patients with incidentally detected pulmonary nodules. PLoS One. 2018; 13:e0197826. 

May

2018

Jett J. et al. Determination of the Detection Lead Time for Autoantibody Biomarkers in Early Stage Lung Cancer Using the UKCTOCS Cohort. Journal of Thoracic Oncology, 12:11S2

Nov

2017

Healey GF et al. Tumor-Associated Autoantibodies: Re-Optimization of EarlyCDT®-Lung Diagnostic Performance and its Application to Indeterminate Pulmonary Nodules. J Cancer Ther. 2017; 8:506-517.

May

2017

Massion PP et al. Autoantibody Signature Enhances the Positive Predictive Power of Computed Tomography and Nodule-Based Risk Models for Detection of Lung Cancer. J Thorac Oncol. 2017; 12:578-584. 

Mar

2017

Mar

2017

Sullivan FM et al. Detection in blood of autoantibodies to tumour antigens as a case-finding method in lung cancer using the EarlyCDT®-Lung Test (ECLS): study protocol for a randomized controlled trial. BMC Cancer. 2017; 17:187.

Mar

2017

Macdonald IK et al. Autoantibodies:Opportunities for Early Cancer Detection. Trends Cancer. 2017; 3:198-213.

Jett JR et al. Audit of the autoantibody test, EarlyCDT®-lung, in 1600 patients: an evaluation of its performance in routine clinical practice. Lung Cancer. 2014; 83:51-5. 

Jan

2014

Healey GF et al. Signal stratification of autoantibody levels in serum samples and its application to the early detection of lung cancer. J Thorac Dis. 2013; 5:618-25.

Oct

2013

Macdonald IK et al. Application of a high throughput method of biomarker discovery to improvement of the EarlyCDT(®)-Lung Test. PLoS One. 2012; 7:e51002.

Dec

2012

Chapman CJ et al. EarlyCDT®-Lung test: improved clinical utility through additional autoantibody assays. Tumour Biol. 2012; 33:1319-26.

Oct

2012

Macdonald IK et al. Development and validation of a high throughput system for discovery of antigens for autoantibody detection. PLoS One. 2012; 7:e40759.

Jul

2012

Lam S et al. EarlyCDT-Lung: an immunobiomarker test as an aid to early detection of lung cancer. Cancer Prev Res (Phila). 2011; 4:1126-34.

Jul

2011

Chapman CJ et al. Immunobiomarkers in small cell lung cancer: potential early cancer signals. Clin Cancer Res. 2011; 17:1474-80.

Mar

2011

Boyle P et al. Clinical validation of an autoantibody test for lung cancer. Ann Oncol. 2011; 22:383-9. 

Feb

2011

Murray A et al. Technical validation of an autoantibody test for lung cancer. Ann Oncol. 2010; 21:1687-1693. 

Aug

2010

logoCUN_Negro.png

©2020 REFINE